Protein tyrosine phosphatases: Mechanisms of catalysis and regulation

Current Opinion in Chemical Biology

Volumn 2, Issue 5, 1998, Pages 633-641

  Denu, John M ^a   Dixon, Jack E ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3CH134 PROTEIN; CELL CYCLE PROTEIN; CELL SURFACE RECEPTOR; IMMEDIATE EARLY PROTEIN; LEUKOCYTE COMMON ANTIGEN RELATED PHOSPHATASE; LEUKOCYTE COMMON ANTIGEN-RELATED PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SHP 1; SIGNAL PEPTIDE; SRC HOMOLOGY 2 (SH2) DOMAIN CONTAINING PHOSPHATASES; SRC HOMOLOGY-2 (SH2) DOMAIN-CONTAINING PHOSPHATASES; THIOSULFATE SULFURTRANSFERASE;

BINDING SITE; CHEMISTRY; ENZYME ACTIVE SITE; EVOLUTION; METABOLISM; PHYSIOLOGY; REVIEW; SRC HOMOLOGY DOMAIN; X RAY CRYSTALLOGRAPHY;

BINDING SITES; CATALYTIC DOMAIN; CELL CYCLE PROTEINS; CRYSTALLOGRAPHY, X-RAY; EVOLUTION; IMMEDIATE-EARLY PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN-TYROSINE-PHOSPHATASE; RECEPTORS, CELL SURFACE; SHP1 PROTEIN TYROSINE PHOSPHATASE; SRC HOMOLOGY DOMAINS; THIOSULFATE SULFURTRANSFERASE;

EID: 0032176512     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(98)80095-1     Document Type: Article

References (58)

1. Hunter T: Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 1995, 80:225-236.
2. Hof P, Pluskey S, Dhe-Paganon S, Eck MJ, Shoelson SE: Crystal structure of the tyrosine phosphatase SHP-2. Cell 1998, 92:441-450. This paper reports the structure of SHP-2 and demonstrates that in the absence of a tyrosine-phosphorylated binding partner, the amino-terminal src homology domain binds the phosphatase domain and directly blocks its active site.
3. Bilwes AM, den Hertog J, Hunter T, Noel JP: Structural basis for inhibition of receptor protein-tyrosine phosphatase-alpha by dimerization. Nature 1996, 382:555-559.
4. Denu JM, Stuckey JA, Saper MA, Dixon JE: Form and function in protein dephosphorylation. Cell 1996, 87:361-364.
5. Fauman EB, Saper MA: Structure and function of the protein tyrosine phosphatases. Trends Biochem Sci 1996, 21:413-417.
6. Barford D: Molecular mechanisms of the protein serine/threonine phosphatases. Trends Biochem Sci 1996, 21:407-412.
7. Guan KL, Broyles SS, Dixon JE: A Tyr/Ser protein phosphatase encoded by vaccinia virus. Nature 1991, 350:359-362.
8. Denu JM, Zhou G, Wu L, Zhao R, Yuvaniyama J, Saper MA, Dixon JE: The purification and characterization of a human dual-specific protein tyrosine phosphatase. J Biol Chem 1995, 270:3796-3803.
9. Sun H, Charles CH, Lau LF, Tonks NK: MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 1993, 75:487-493.
10. Stuckey JA, Schubert HL, Fauman EB, Zhang ZY, Dixon JE, Saper MA: Crystal structure of Yersinia protein tyrosine phosphatase at 2.5 Å and the complex with tungstate. Nature 1994, 370:571-575.
11. Barford D, Flint AJ, Tonks NK: Crystal structure of human protein tyrosine phosphatase 1 B. Science 1994, 263:1397-1404.
12. Yuvaniyama J, Denu JM, Dixon JE, Saper MA: Crystal structure of the dual specificity protein phosphatase VH R. Science 1996, 272:1328-1331.
13. Zhang M, Van Etten RL, Stauffacher CV: Crystal structure of bovine heart phosphotyrosyl phosphatase at 2.2 Å resolution. Biochemistry 1994, 33:11097-11105.
14. Su XD, Taddei N, Stefani M, Ramponi G, Nordlund P: The crystal structure of a low-molecular-weight phosphotyrosine protein phosphatase. Nature 1994, 370:575-578.
15. Dunphy WG, Kumagai A: The cdc25 protein contains an intrinsic phosphatase activity. Cell 1991, 67:189-196.
16. Gautier J, Solomon MJ, Booher RN, Bazan JF, Kirschner MW: p80cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2. Cell 1991, 67:197-211.
17. Millar JB, McGowan CH, Lenaers G, Jones R, Russell P: p80cdc25 mitotic inducer is the tyrosine phosphatase that activates p34cdc2 kinase in fission yeast. EMBO J 1991, 10:4301-4309.
18. Fauman EB, Cogswell JP, Lovejoy B, Rocque WJ, Holmes W, Montana WG, Piwnica-Worms H, Rink MJ, Saper MA: Crystal structure of the catalytic domain of the human cell cycle control phosphatase, Cdc25A. Cell 1998, 93:617-625. The first X-ray structure of the cell cycle phosphate cdc25A is discussed.
19. Gottlin E, Xu X, Epstein D, Burke S, Eckstein J, Batton D, Dixon JE: Kinetic analysis of the catalytic domain of human cdc25B. J Biol Chem 1996, 271:27445-27449.
20. Bobrowicz P, Wysocki R, Owsianik G, Goffeau A, Ulaszewski S: Isolation of three contiguous genes, ACR1, ACR2 and ACR3, involved in resistance to arsenic compounds in yeast Saccharmyces cerevisiae. Yeast 1997, 13:819-828.
21. Tonks NK, Neel BG: From form to function: signaling by protein tyrosine phosphatases. Cell 1996, 87:365-368.
22. Neel BG, Tonks NK: Protein tyrosine phosphatases in signal transduction. Curr Opin Cell Biol 1997, 9:193-204. This is a thorough review of the physiological functions of protein tyrosine phosphatases.
23. Frangioni JV, Beahm PH, Shifrin V, Jost CA, Neel BG: The nontransmembrane tyrosine phosphatase PTP-1 B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence. Cell 1992, 68:545-560.
24. Lorenzen JA, Dadabay CY, Fischer EH: COOH-terminal sequence motifs target the T cell protein tyrosine phosphatase to the ER and nucleus. J Cell Biol 1995, 131:631-643.
25. McLaughlin S, Dixon JE: Alternative splicing gives rise to a nuclear protein tyrosine phosphatase in Drosophila. J Biol Chem 1993, 268:6839-6842.
26. Brady-Kalnay SM, Rimm DL, Tonks NK: Receptor protein tyrosine phosphatase PTPmu associates with cadherins and catenins in vivo. J Cell Biol 1995, 130:977-986.
27. Sap J, Jiang YP, Friedlander D, Grumet M, Schlessinger J: Receptor tyrosine phosphatase R-PTP-kappa mediates homophilic binding. Mol Cell Biol 1994, 14:1-9.
28. Cheng J, Wu K, Armanini M, O'Rourke N, Dowbenko D, Lasky LA: A novel protein-tyrosine phosphatase related to the homotypically adhering kappa and mu receptors. J Biol Chem 1997, 272:7264-7277.
29. Fuchs M, Muller T, Lerch MM, Ullrich A: Association of human protein-tyrosine phosphatase kappa with members of the armadillo family. J Biol Chem 1996, 271:16712-16719.
30. Jia Z, Barford D, Flint AJ, Tonks NK: Structural basis for phosphotyrosine peptide recognition by protein tyrosine phosphatase 1 B. Science 1995, 268:1754-1758.
31. Zhang ZY, Wang Y, Wu L, Fauman EB, Stuckey JA, Schubert HL, Saper MA, Dixon JE: The Cys(X)5Arg catalytic motif in phosphoester hydrolysis. Biochemistry 1994, 33:15266-15270.
32. Denu JM, Zhou G, Guo Y, Dixon JE: The catalytic role of aspartic acid-92 in a human dual-specific protein- tyrosine-phosphatase. Biochemistry 1995, 34:3396-3403.
33. Lohse DL, Denu JM, Santoro N, Dixon JE: Roles of aspartic acid-181 and serine-222 in intermediate formation and hydrolysis of the mammalian protein-tyrosine-phosphatase PTP1. Biochemistry 1997, 36:4568-4575.
34. Zhang ZY, Dixon JE: Active site labeling of the Yersinia protein tyrosine phosphatase: the determination of the pKa of the active site cysteine and the function of the conserved histidine 402. Biochemistry 1993, 32:9340-9345.
35. Pot DA, Woodford TA, Remboutsika E, Haun RS, Dixon JE: Cloning, bacterial expression, purification, and characterization of the cytoplasmic domain of rat LAR, a receptor-like protein tyrosine phosphatase. J Biol Chem 1991, 266:19688-19696.
36. Cho H, Krishnaraj R, Kitas E, Bannwarth W, Walsh CT, Anderson KS: Isolation and structural elucidation of a novel phosphocysteine intermediate in the LAR protein tyrosine phosphatase enzymatic pathway. J Am Chem Soc 1993, 114:7296-7298.
37. Denu JM, Lohse DL, Vijayalakshmi J, Saper MA, Dixon JE: Visualization of intermediate and transition-state structures in protein-tyrosine phosphatase catalysis. Proc Natl Acad Sci US 1996, 93:2493-2498.
38. Pannifer ADB, Flint AJ, Tonks NK, Barford D: Visualization of the cysteinyl-phosphate intermediate of a protein-tyrosine phosphatase by X-ray crystallography. J Biol Chem 1998, 273:10454-10462. This account describes the crystal structure of the phosphoenzyme intermediate of a Gln262→Ala mutant of protein tyrosine phosphatase 1 B. The structure highlights the important catalytic residues.
39. Zhang ZY, Wang Y, Dixon JE: Dissecting the catalytic mechanism of protein-tyrosine phosphatases. Proc Natl Acad Sci USA 1994, 91:1624-1627.
40. Hengge AC, Denu JM, Dixon JE: Transition-state structures for the native dual-specific phosphatase VHR and D92N and S131A mutants. Contributions to the driving force for catalysis. Biochemistry 1996 35:7084-7092.
41. Hengge AC, Sowa GA, Wu L, Zhang, ZY: Nature of the transition state of the protein tyrosine phosphatase-catalyzed reaction. Biochemistry 1995, 34:13982-13987.
42. Denu JM, Dixon JE: A catalytic mechanism for the dual-specific phosphatases. Proc Natl Acad Sci USA 1995, 92:5910-5914.
43. Huyer G, Liu S, Kelly J, Moffat J, Payette P, Kennedy B, Tsaprailis G, Gresser MJ, Ramachandran C: Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. J Biol Chem 1997, 272:843-851. A mechanistic and chemical investigation into the basis of vanadate and peroxy-vanadate inhibition of protein tyrosine phosphatases.
44. Sugimoto S, Lechleider RJ, Shoelson SE, Neel BG, Walsh CT: Expression, purification, and characterization of SH2-containing protein tyrosine phosphatase, SH-PTP2. J Biol Chem 1993, 268:22771-22776.
45. Lechleider RJ, Sugimoto S, Bennett AM, Kashishian AS, Cooper JA, Shoelson SE, Walsh CT, Neel BG: Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor. J Biol Chem 1993, 268:21478-21481.
46. Pluskey S, Wandless TJ, Walsh CT, Shoelson SE: Potent stimulation of SH-PTP2 phosphatase activity by simultaneous occupancy of both SH2 domains. J Biol Chem 1995, 270:2897-2900.
47. Schubert HL, Fauman EB, Stuckey JA, Dixon JE, Saper MA: A ligand-induced conformational change in the Yersinia protein tyrosine phosphatase. Protein Sci 1995, 4:1904-1913.
48. Eck MJ, Pluskey S, Trub T, Harrison SC, Shoelson SE: Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2. Nature 1996, 379:277-280.
49. Hoffmann KM, Tonks NK, Barford D: The crystal structure of domain 1 of receptor protein-tyrosine phosphatase mu. J Biol Chem 1997, 272:27505-27508. This report directly argues against a general mechanism for regulating the activity of receptor-like protein tyrosine phosphatases by ligand-induced dimerization.
50. Majeti R, Bilwes AM, Noel JP, Hunter T, Weiss A: Dimerization induced inhibition of receptor protein tyrosine phosphatase function through an inhibitory wedge. Science 1998, 279:88-91. This study provides evidence for physiological dimerization of receptor-like protein tyrosine phosphatases (RPTPs). This conclusion was made on the basis of the signaling properties of an epidermal growth factor (EGF)-CD45 chimeric receptor, containing the intracellular region from RPTP CD45 and the extracellular domain of the EGF receptor.
51. Monteiro HP, Stern A: Redox modulation of tyrosine phosphorylation-dependent signal transduction pathways. Free Radic Biol Med 1996, 21:323-333.
52. Suzuki YJ, Forman HJ, Sevanian A: Oxidants as stimulators of signal transduction. Free Radical Biol Med 1997, 22:269-285. This paper discusses the physiological significance of the role of biological oxidants in the regulation of signal transduction as well as the mechanisms of the oxidant-stimulation of signal transduction.
53. Knebel A, Rahmsdorf HJ, Ullrich A, Herrlich P: Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. EMBO J 1996, 15:5314-5325.
54. Denu JM, Tanner KG: Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry 1998, 37:5633-5642. This study provides direct biochemical evidence that protein tyrosine phosphatases are a viable target of cellular oxidants. The catalytic cysteine was shown to be specifically and reversibly oxidized. Reaction with hydrogen peroxide involves the initial formation of a sulfenic acid to generate inactive enzyme. Reactivation was accomplished with reduced thiols
55. 2 for platelet-derived growth factor signal transduction. Science 1995, 270:296-299.
56. Bae YS, Kang SW, Seo MS, Baines IC, Tekle E, Chock PB, Rhee SG: Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem 1997, 272:217-221.
57. Yamauchi A, Bloom ET: Control of cell cycle progression in human natural killer cells through redox regulation of expression and phosphorylation of retinoblastoma gene product protein. Blood 1997, 89:4092-4099.
58. Bilwes AM, den Hertog J, Hunter T, Noel JP: Structural basis for inhibition of receptor protein-tyrosine phosphatase-α by dimerization. Nature 1996, 382:555-559.